ImmunoChemistry Technologies, LLC

ImmunoChemistry Technologies, LLC (ICT) is a biotechnology company headquartered in Davis, California, USA, established in 1994. Specializing in cell viability assays, immunoassays, and assay services, ICT boasts a team with decades of assay and protein chemistry expertise.

ICT's range of products includes coating buffers, blockers, sample and assay diluents, conjugate stabilizers, and wash buffer – all designed to minimize the build-up of unwanted proteins and ensure a clean signal, addressing common issues encountered during ELISA and assay development.

Offering an extensive array of fluorescent whole cell assays for intracellular apoptosis detection and cellular analysis, ICT's viability assays cover various indicators such as apoptosis, necrosis, intracellular caspase activity, cell-mediated cytotoxicity, activated serine proteases, oxidative stress, and mitochondrial membrane permeability, among others.

Moreover, ICT’s service laboratory provides an array of immunoassay and assay-related services. The team's extensive experience in protein chemistry and assay optimization allows them to scale up and manufacture assays for internal use. The wide product range caters to immunoassay and molecular diagnostics applications.

Although specific details regarding the latest investment remain unavailable, ImmunoChemistry Technologies, LLC positions itself as a promising venture within the biotechnology sector. Their comprehensive product line and proficiency in assay development and services indicate the potential for further growth and industry impact.